Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03639727
Other study ID # KUH5801136
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 1, 2018
Est. completion date January 31, 2019

Study information

Verified date February 2019
Source Kuopio University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Comparison of citric acid and mannitol cough provocation tests among subjects with chronic cough and healthy volunteers.


Description:

35 subjects with chronic cough plus 25 subjects without any cough will be asked to participate. The study consists of two visits in the outpatient clinic of Kuopio University Hospital, department of respiratory medicine, 2 - 7 days apart. They will fill in the Leicester Cough Questionnaire and undergo two different cough provocation tests, in random order: Mannitol test and citric acid test. If a chest x-ray has not been taken within 6 months, it will be taken.


Recruitment information / eligibility

Status Completed
Enrollment 61
Est. completion date January 31, 2019
Est. primary completion date December 31, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria, Chronic cough patients:

(both criteria must be fulfilled)

- presence of current chronic cough (> 8 weeks)

- Leicester Cough Questionnaire total score < 17

Inclusion criteria, healthy volunteers

- absence of any form of cough

Exclusion Criteria:

- age < 18 years

- any disability which would challenge the subject's ability to understand the purpose and methods of the study

- pregnancy

- breastfeeding

- current smoking or ex smoking more than 10 pack years

- any thoracic x-ray finding indicating urgent mediacal interventions

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Citric acid aerosol bronchial challenge
Inhalation challenge by citric acid aerosol to investigate the subject's cough sensitivity
Mannitol aerosol bronchial challenge
Inhalation challenge by mannitol aerosol to investigate the subject's cough sensitivity

Locations

Country Name City State
Finland Kuopio University Hospital Kuopio

Sponsors (2)

Lead Sponsor Collaborator
Kuopio University Hospital Helsinki University

Country where clinical trial is conducted

Finland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Receiver operator characteristic curves of the citric acid and the mannitol aerosol bronchial challenges Receiver operator characteristic curve describes the ability of the bronchial challenge to separate the cough patients from healthy volunteers Within one week from the start of the study in each individual
Secondary Leicester Cough Questionnaire total score Measures cough-spesific quality of life. Range is 3 - 21 with low total score indicating poor cough-spesific quality of life. The three Leicester Cough Questionnaire subscales are added together to form the total score. The first study day
See also
  Status Clinical Trial Phase
Completed NCT01432730 - A Study to Assess the Efficacy of Gefapixant (MK-7264/AF-219), in Participants With Chronic Cough (MK-7264-006) Phase 2
Not yet recruiting NCT01413698 - Cough Count Validation N/A
Completed NCT03696108 - A Study of Gefapixant (MK-7264) in Japanese Adult Participants With Refractory or Unexplained Chronic Cough (MK-7264-038) Phase 3
Recruiting NCT03638063 - ATP and Capsaicin Cough Provocation Test in Chronic Cough and Bronchiectasis
Recruiting NCT06376448 - An Observational Study Using Novel Questionnaire to Characterize Cough Phenotypes in Patients With Chronic Cough
Completed NCT03172130 - Sham CPAP vs. Straight CPAP for Chronic Cough N/A
Recruiting NCT06286163 - Neuroinflammatory Interactions of ATP and P2X3 Receptor in the Airways of Chronic Cough Patients
Completed NCT03622216 - A Dose Escalation Study of Bradanicline in Refractory Chronic Cough Phase 2
Recruiting NCT05522699 - Cough Suppressive Therapy in Patients With Chronic Cough N/A
Completed NCT01297790 - Cough Responses to Tussive Agents in Health and Disease N/A
Completed NCT04193202 - Efficacy and Safety of Gefapixant (MK-7264) in Adult Participants With Recent Onset Chronic Cough (MK-7264-043) Phase 3
Completed NCT01865422 - French Linguistic and Metric Validations of Parent-proxy QOL Chronic Cough Specific Questionnaire (PC-QOL) N/A
Completed NCT04525885 - A Study of Gefapixant (MK-7264) in Adult Participants With Chronic Cough (MK-7264-030)-China Extension Phase 3
Completed NCT04193176 - Efficacy and Safety of Gefapixant (MK-7264) in Women With Chronic Cough and Stress Urinary Incontinence (MK-7264-042) Phase 3
Recruiting NCT05362097 - Analysis of the Reliability and Validity of the Chinese Version of CC-QoL
Recruiting NCT03787511 - Chronic Cough and Small Fiber Neuropathy N/A
Terminated NCT03864328 - A Phase 2b Study of Inhaled RVT-1601 for the Treatment of Persistent Cough in IPF Phase 2
Completed NCT05274516 - A Trial of HRS-2261 in Healthy Subjects After Single and Multiple Oral Administration Phase 1
Not yet recruiting NCT01807832 - The Use of Capsaicin Challenge for Diagnosis, Monitoring and Follow-up of Chronic Cough. N/A
Enrolling by invitation NCT05689307 - Validation Study With a Non-CE Marked Medical Device (MD) N/A